Skip to content
PAYXPaychex

What Is PAYX Fair Value?

Paychex (PAYX) fair value estimate using multiple valuation models, updated daily.

As of July 16, 2026, Paychex (PAYX) has a composite fair value estimate of $61.50 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $110.00, suggesting the stock is overvalued by 44.1%.

Data as of July 16, 2026 (today)

Composite Fair Value

Overvalued4 of 4 models

$61.50

vs. current price of $110.00(-44.1%)

Undervalued$61.50Overvalued
$110.00

How Is PAYX Fair Value Calculated?

Four independent models estimate what PAYX is worth. Each uses different inputs and assumptions. The composite blends them by weight.

PAYX Intrinsic Value

Forward-looking models based on future cash flows

DCF (Discounted Cash Flow)

35% weight

Estimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →

$60.99

-44.6%

Overvalued

Inputs used

FCF: 1.3BGrowth: 7.7%Discount: 9%

DDM (Dividend Discount Model)

15% weight

If a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →

$80.17

-27.1%

Overvalued

Inputs used

Dividend: $4.76/yrReq. Return: 10%Growth: 3.8%

PAYX Fair Value

Current fundamentals: earnings, assets, and growth rate

Graham Number (Value Investing)

25% weight

Created by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →

$37.60

-65.8%

Overvalued

Inputs used

EPS: $5.98Book Value: $10.50

PEG (Price/Earnings to Growth)

25% weight

Checks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.

$59.83

-45.6%

Overvalued

Inputs used

EPS: $5.98Growth: 7.7%

What If You Change the Assumptions?

Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.

Your DCF Fair Value

$60.99Overvalued

Current price $110.00 is 44.6% above this estimate

CheapFair ValueExpensive
7.7%
0.0%30.0%
9.4%
6.0%15.0%
2.5%
1.0%4.0%
15.0%
0.0%50.0%
View 10-year cash flow projections
YearProjected FCF (Free Cash Flow)Present Value
Year 1$1.42B$1.30B
Year 2$1.53B$1.28B
Year 3$1.65B$1.26B
Year 4$1.77B$1.24B
Year 5$1.91B$1.22B
Year 6$2.06B$1.20B
Year 7$2.21B$1.18B
Year 8$2.38B$1.17B
Year 9$2.57B$1.15B
Year 10$2.76B$1.13B
Terminal Value$41.29B$16.87B

What Are PAYX's Key Financial Metrics?

Earnings & Growth

Current Price

$110.00

EPS (TTM)

$4.91

Forward P/E

17.2

Profit Margin

26.6%

Cash & Balance Sheet

Free Cash Flow

0

EBITDA

1.6B

Book Value

$10.50

Total Debt

4.6B

What Do Analysts Say About PAYX?

Low

$90.00

Average

$106.57

High

$140.00

Upside

-3.1%

Current $110.00Avg Target $106.57Hold14 analysts

PAYX Fair Value FAQ

What is the fair value of PAYX?

Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), PAYX's estimated fair value is $61.50. The stock is currently trading at $110.00, which makes it overvalued by our analysis.

How is PAYX's fair value calculated?

We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.

Is PAYX overvalued or undervalued?

Based on our analysis, PAYX is overvalued. The current price of $110.00 is 44.1% above our estimated fair value of $61.50.

What do Wall Street analysts say about PAYX?

14 analysts cover Paychex with a consensus rating of "Hold." The average price target is $106.57, ranging from $90.00 to $140.00. This implies 3.1% downside from the current price.